DCM
WGS icon

Dupont Capital Management’s GeneDx Holdings WGS Stock Holding History

Dupont Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Hold
0
– – – 1846
2021
Q3 		– Hold
0
– – – 1835
2021
Q1 		– Sell
-606
Closed -$221K – 1660
2020
Q4 		$221K Buy
+606
New +$211K ﹤0.01% 1118

Other funds holding WGS

Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
Third Point
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Dupont Capital Management's WGS Position: Q4 2021 in Review

Dupont Capital Management held its GeneDx Holdings (WGS) position steady in Q4 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

Dupont Capital Management first reported a position in WGS in Q4 2020 and has held it in 1 quarter since. The position peaked at $221K in Q4 2020. 112 funds tracked by Wall St. Rank hold WGS as of Q4 2021.

  • Dupont Capital Management held 0 shares of GeneDx Holdings worth $0 as of Q4 2021.
  • Dupont Capital Management left its GeneDx Holdings share count unchanged in Q4 2021.
  • GeneDx Holdings made up ﹤0.01% of Dupont Capital Management's portfolio in Q4 2021, its #1846 holding.
  • Dupont Capital Management first reported a position in GeneDx Holdings in Q4 2020 and has held it in 1 quarter since.
  • Dupont Capital Management's GeneDx Holdings position peaked at $221K in Q4 2020.
  • 112 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2021.

Based on Dupont Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.